Effect of thiazolidinediones on bile acid transport in rat liver

This publication has 38 references indexed in Scilit:

• Troglitazone and liver injury
  Hepatology, 2005
• Severe Cholestatic Hepatitis Caused by Thiazolidinediones: Risks Associated with Substituting Rosiglitazone for Troglitazone
  Digestive Diseases and Sciences, 2002
• Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate
  Toxicology, 2001
• The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
  Clinical Pharmacology & Therapeutics, 2001
• Cholestatic Potential of Troglitazone as a Possible Factor Contributing to Troglitazone-Induced Hepatotoxicity: In Vivo and in Vitro Interaction at the Canalicular Bile Salt Export Pump (Bsep) in the Rat
  Molecular Pharmacology, 2001
• Hepatic Failure in a Patient Taking Rosiglitazone
  Annals of Internal Medicine, 2000
• Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
  Annals of Internal Medicine, 2000
• Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone
  Annals of Internal Medicine, 1998
• Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver
  Gastroenterology, 1994
• Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent
  Diabetes, 1983